The United States is a key consumer of fodder additives like emulsifiers, vitamins, and enzymes, driven by a robust animal production sector. Strict food safety regulations surrounding additive use ...
UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...